Network Pharmacology Identifies Stigmasterol as an Anti-Gastric Cancer Agent Targeting HSP90AA1 for Ubiquitin-Mediated Degradation.

Zhang H, Zhang Y, Ling Y, Jiang G, Wu J, Shi X, Zhao Y

Open source

DOI
10.3791/73515
Published
2026 Nov 3
Container
Journal of visualized experiments : JoVE
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3791/73515,
  title = {Network Pharmacology Identifies Stigmasterol as an Anti-Gastric Cancer Agent Targeting HSP90AA1 for Ubiquitin-Mediated Degradation.},
  author = {Zhang H and Zhang Y and Ling Y and Jiang G and Wu J and Shi X and Zhao Y},
  year = {2026},
  journal = {Journal of visualized experiments : JoVE},
  doi = {10.3791/73515},
  url = {https://doi.org/10.3791/73515}
}

RIS

TY  - JOUR
TI  - Network Pharmacology Identifies Stigmasterol as an Anti-Gastric Cancer Agent Targeting HSP90AA1 for Ubiquitin-Mediated Degradation.
AU  - Zhang H
AU  - Zhang Y
AU  - Ling Y
AU  - Jiang G
AU  - Wu J
AU  - Shi X
AU  - Zhao Y
PY  - 2026
JO  - Journal of visualized experiments : JoVE
DO  - 10.3791/73515
UR  - https://doi.org/10.3791/73515
ER  - 

APA

H, Z., Y, Z., Y, L., G, J., J, W., X, S., & Y, Z. (2026). Network Pharmacology Identifies Stigmasterol as an Anti-Gastric Cancer Agent Targeting HSP90AA1 for Ubiquitin-Mediated Degradation.. Journal of visualized experiments : JoVE. https://doi.org/10.3791/73515

Source records